Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Fellowship - Priority Announcement: Amyotrophic Lateral Sclerosis

University of Toronto

$0.00

Translational Profiling in Transgenic Mouse Models of ALS

FY 2008-09

Summary
Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease, is an adult-onset neurodegenerative disease caused by the progressive loss of motor neurons from the brain and spinal cord. The disease starts as a mild muscle weakness that progresses to complete paralysis and death, usually within 2-5 years from diagnosis. There is no cure nor effective treatment. Mutations in a gene called superoxide dismutase (SOD1) cause some forms of the disease, and transgenic mice expressing this gene develop a disease very similar to ALS. The aim of this project is to identify the changes in gene expression that occur in the motor neurons of mice expressing mutant SOD1 as means to understanding how the disease occurs and what can be done to prevent it.
Program
Fellowship - Priority Announcement: Amyotrophic Lateral Sclerosis
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
185130
Name
Zhao Beibei
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Partnername
Amyotrophic Lateral Sclerosis Society of Canada
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Translational Profiling in Transgenic Mouse Models of ALS
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$0
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement: Amyotrophic Lateral Sclerosis
Keyworddelim
Amyotrophic Lateral Sclerosis; Microarray; Mutant Superoxide Dismutase-1; Q-Rt-Pcr; Transgenic Mice; Translational Profiling
Abstract
Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease, is an adult-onset neurodegenerative disease caused by the progressive loss of motor neurons from the brain and spinal cord. The disease starts as a mild muscle weakness that progresses to complete paralysis and death, usually within 2-5 years from diagnosis. There is no cure nor effective treatment. Mutations in a gene called superoxide dismutase (SOD1) cause some forms of the disease, and transgenic mice expressing this gene develop a disease very similar to ALS. The aim of this project is to identify the changes in gene expression that occur in the motor neurons of mice expressing mutant SOD1 as means to understanding how the disease occurs and what can be done to prevent it.
Competitiondate
200902
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Zhao, Beibei
Approvedterm
3 ans 0 mois
University of Toronto - $0 Grant (2008-09) | Canada Spends